Biogen Inc. buy Haans
Start price
19.07.16
/
50%
€236.03
Target price
02.08.16
€280.00
Performance (%)
23.10%
End price
02.08.16
€290.55
Summary
This prediction ended on 02.08.16 with a price of €290.55. The prediction had a final performance of 23.10%. Haans has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biogen Inc. | 5.009% | 5.009% | 4.594% | -45.624% |
| iShares Core DAX® | -0.121% | 2.507% | 16.129% | 61.530% |
| iShares Nasdaq 100 | 0.081% | -0.241% | 4.636% | 97.770% |
| iShares Nikkei 225® | -1.748% | 4.105% | 16.103% | 48.713% |
| iShares S&P 500 | -0.961% | -0.143% | 1.644% | 62.430% |
Comments by Haans for this prediction
In the thread Biogen Inc. diskutieren
Gewinnt an Stärke...
Biogen, wie auch der gesamte Biotech-Sektor gewinnt deutlich an Stärke. Biotech wird bald wieder zu den Outperformern gehören. Es ist an der Zeit sich langsam zu positionieren.